SCHEMBL14694874

SCHEMBL14694874

OCC(F)(F)COc1ccc(C(F)(F)c2ccc(OCC(O)CCl)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ AR P10275 1/20 0.56
▸ HTT P42858 3/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ CACNA1G O43497 6/20 0.38
▸ MAPT P10636 4/20 0.37
▸ GAA P10253 1/20 0.37
▸ KCNH2 Q12809 4/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ LMNA P02545 2/20 0.34
▸ POLB P06746 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ SCN1A P35498 1/20 0.34
▸ SCN5A Q14524 1/20 0.34
▸ SCN9A Q15858 1/20 0.34
▸ CYP1A2 P05177 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14695862 1.00 AR (0.56) ARHTTHIF1ACACNA1GMAPT
SCHEMBL14696192 1.00 AR (0.56) ARHTTHIF1ACACNA1GMAPT
SCHEMBL14694904 0.90 AR (0.71) ARHTTHIF1ACACNA1GMAPT
SCHEMBL14694978 0.90 AR (0.71) ARHTTHIF1ACACNA1GMAPT
SCHEMBL14695495 0.90 AR (0.71) ARHTTHIF1ACACNA1GMAPT
SCHEMBL14707387 0.85 AR (0.42) ARHTTHIF1ACACNA1GMAPT
SCHEMBL14695730 0.83 AR (0.57) ARHTTHIF1ACACNA1GMAPT
SCHEMBL14695277 0.83 AR (0.57) ARHTTHIF1ACACNA1GMAPT
SCHEMBL14695268 0.83 AR (0.57) ARHTTHIF1ACACNA1GMAPT
SCHEMBL14695096 0.83 AR (0.57) ARHTTHIF1ACACNA1GMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2744773-B1 FLUORINATED BISPHENOL ETHER COMPOUNDS AND METHODS FOR THEIR USE BRITISH COLUMBIA CANCER AGENCY (CA) 2016-11-02 — — EP disclosed
EP-2744773-B1 FLUORINATED BISPHENOL ETHER COMPOUNDS AND METHODS FOR THEIR USE BRITISH COLUMBIA CANCER AGENCY (CA) 2016-11-02 — — EP disclosed
WO-2013028572-A1 FLUORINATED BISPHENOL ETHER COMPOUNDS AND METHODS FOR THEIR USE BRITISH COLUMBIA CANCER AGENCY BRANCH (CA) 2013-02-28 — — WO disclosed
US-20130045204-A1 FLUORINATED BISPHENOL ETHER COMPOUNDS AND METHODS FOR THEIR USE THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2013-02-21 — — US disclosed
US-20130045204-A1 FLUORINATED BISPHENOL ETHER COMPOUNDS AND METHODS FOR THEIR USE THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2013-02-21 — — US disclosed
US-20130045204-A1 FLUORINATED BISPHENOL ETHER COMPOUNDS AND METHODS FOR THEIR USE THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2013-02-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130045204-A1 FLUORINATED BISPHENOL ETHER COMPOUNDS AND METHODS FOR THEIR USE AR, ESRRA, ESR1 AR 1/4885HTT 3985/4885HIF1A 3869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback